Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Memorial Sloan Kettering Cancer Center Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/10/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/15/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/17/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/07/2018 SC 13G Memorial Sloan-Kettering Cancer Center reports a 8% stake in Y-mAbs Therapeutics, Inc.
02/12/2018 SC 13G/A Memorial Sloan-Kettering Cancer Center reports a 1.5% stake in Actinium Pharmaceuticals, Inc.
02/10/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/15/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/01/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 23,500 shares @ $1.8, valued at $42.3k
Sold 1,500 shares @ $1.805, valued at $2.7k
Sold 30,474 shares @ $1.81, valued at $55.2k
Sold 200 shares @ $1.8125, valued at $362.5
Sold 300 shares @ $1.815, valued at $544.5
Sold 100 shares @ $1.82, valued at $182
Sold 25,188 shares @ $1.8, valued at $45.3k
Sold 6,400 shares @ $1.81, valued at $11.6k
Sold 200 shares @ $1.815, valued at $363
Sold 25,100 shares @ $1.82, valued at $45.7k
Sold 800 shares @ $1.83, valued at $1.5k
08/30/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 12,998 shares @ $1.7, valued at $22.1k
Sold 12,002 shares @ $1.71, valued at $20.5k
Sold 12,500 shares @ $1.71, valued at $21.4k
Sold 12,500 shares @ $1.72, valued at $21.5k
08/17/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 4,439 shares @ $1.72, valued at $7.6k
Sold 4,629 shares @ $1.72, valued at $8k
Sold 400 shares @ $1.725, valued at $690
07/14/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 3,000 shares @ $1.8, valued at $5.4k
Sold 100 shares @ $1.81, valued at $181
07/07/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 6,000 shares @ $1.82, valued at $10.9k
Sold 4,340 shares @ $1.83, valued at $7.9k
Sold 10,500 shares @ $1.8, valued at $18.9k
07/05/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 15,200 shares @ $1.8, valued at $27.4k
Sold 300 shares @ $1.8025, valued at $540.8
Sold 300 shares @ $1.805, valued at $541.5
Sold 3,350 shares @ $1.82, valued at $6.1k
Sold 44,841 shares @ $1.8, valued at $80.7k
Sold 3,200 shares @ $1.8001, valued at $5.8k
Sold 200 shares @ $1.8015, valued at $360.3
Sold 100 shares @ $1.8025, valued at $180.3
Sold 11,350 shares @ $1.805, valued at $20.5k
Sold 25,800 shares @ $1.81, valued at $46.7k
Sold 7,362 shares @ $1.8101, valued at $13.3k
07/05/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
06/17/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 33,619 shares @ $1.9, valued at $63.9k
06/06/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 11,000 shares @ $2, valued at $22k
Sold 6,790 shares @ $2.02, valued at $13.7k
06/02/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 18,110 shares @ $1.9, valued at $34.4k
Sold 1,890 shares @ $1.905, valued at $3.6k
Sold 19,700 shares @ $1.92, valued at $37.8k
Sold 300 shares @ $1.9201, valued at $576
Sold 23,837 shares @ $1.93, valued at $46k
Sold 100 shares @ $1.9301, valued at $193
Sold 600 shares @ $1.9315, valued at $1.2k
Sold 300 shares @ $1.935, valued at $580.5
Sold 56,954 shares @ $1.94, valued at $110.5k
Sold 790 shares @ $1.945, valued at $1.5k
Sold 6,755 shares @ $1.95, valued at $13.2k
05/31/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 27,168 shares @ $1.92, valued at $52.2k
Sold 12,700 shares @ $1.93, valued at $24.5k
Sold 200 shares @ $1.935, valued at $387
05/26/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/26/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 3,041 shares @ $2.06, valued at $6.3k
Sold 19,759 shares @ $2.07, valued at $40.9k
Sold 100 shares @ $2.0725, valued at $207.3
Sold 1,000 shares @ $2.075, valued at $2.1k
Sold 3,692 shares @ $2.08, valued at $7.7k
Sold 100 shares @ $2.09, valued at $209
Sold 1,800 shares @ $2, valued at $3.6k
Sold 200 shares @ $2.0025, valued at $400.5
Sold 500 shares @ $2.005, valued at $1k
Sold 7,600 shares @ $2.01, valued at $15.3k
Sold 400 shares @ $2.0125, valued at $805
04/21/2016 4 Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Sold 4,517 shares @ $2.065, valued at $9.3k
Sold 2,133 shares @ $2.07, valued at $4.4k
Sold 3,420 shares @ $2.0701, valued at $7.1k
Sold 600 shares @ $2, valued at $1.2k
Sold 200 shares @ $2.01, valued at $402
Sold 4,000 shares @ $2.02, valued at $8.1k
Sold 18,224 shares @ $2.03, valued at $37k
Sold 10,473 shares @ $2.04, valued at $21.4k
Sold 9,300 shares @ $2.04, valued at $19k
Sold 3,700 shares @ $2.05, valued at $7.6k
Sold 49,509 shares @ $2, valued at $99k
04/21/2016 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy